Beyond approval: Patients pursue alternate paths to get rare disease treatments
As post-approval boundaries disproportionately affect rare disease patients, communities are rallying behind alternative options.
As post-approval boundaries disproportionately affect rare disease patients, communities are rallying behind alternative options.
What's Your Reaction?
